Determination of acute leukemia lineage with new morphologic parameters available in the complete blood cell count.
OBJECTIVE
Cell population data (CPD) are new morphologic parameters including volume, conductivity, and five light scattering characteristics used for leukocyte classification by an automated hematology analyzer, the UniCel DxH 800. We developed a discriminating CPD model to predict the leukemia lineage during routine complete blood cell count (CBC).


METHODS
We analyzed the CPD of 405 blood samples containing more than 10% blasts that were randomly divided into test and validation sets. With the test set, we produced a model for categorizing acute lymphoblastic leukemia (ALL) or acute promyelocytic leukemia (APL), using ranges of the CPD and regarding the remainder as non-APL acute myeloid leukemia. We verified these models against the validation set.


RESULTS
In the test set, we formulated a 21-parameter model which identified 43 of 47 ALL cases (91.5% sensitivity) and ruled out 151 of 156 other leukemia cases (96.8% specificity), and a 13-parameter model which distinguished all 10 APL cases (100% sensitivity) and excluded 193 other leukemia cases (100% specificity). In the validation set, the ALL model showed 85.1% sensitivity and 94.2% specificity, and the APL model 100% sensitivity and 100% specificity.


CONCLUSIONS
This study demonstrated a new solution for predicting blast lineage using the CPD on a CBC and leukocyte differential.
Department of Laboratory Medicine, College of Medicine, the Catholic University of Korea, Seoul St. Mary's Hospital, 505 Banpo-dong, Seocho-gu, Seoul 137-701, South Korea; phone: +82 2 2258 1644; fax: +82 2 2258 1719; e mail: hankja@catholic.ac.kr.
Jin Hyuk
JH
Yang
Yonggoo
Y
Kim
Jihyang
J
Lim
Myungshin
M
Kim
Eun-Jee
EJ
Oh
Hae-Kyung
HK
Lee
Yeon-Joon
YJ
Park
Woo Sung
WS
Min
Bin
B
Cho
Kwangyoung
K
Lee
Kyungja
K
Han
D001772:Blood Cell Count; D019070:Cell Lineage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000473:pathology*; D008954:Models, Biological
ALL; AML; Acute leukemia; and Leukocytes morphology